Lisa Kurnia Sari
Universitas Kristen Duta Wacana

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Efektivitas Terapi Metformin dalam Mencapai Target Kadar HbA1c Ni Kadek Ayu Kunti Pertiwi; Lisa Kurnia Sari; Hendi Wicaksono; Tejo Jayadi
SEHATMAS: Jurnal Ilmiah Kesehatan Masyarakat Vol. 4 No. 4 (2025): Oktober 2025
Publisher : Yayasan Literasi Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55123/sehatmas.v4i4.6349

Abstract

Type 2 Diabetes Mellitus (T2DM) is a chronic disease with high prevalence in Indonesia, include Bantul Regency,Yogyakarta. In September 2024 the number of cases reached 18,520, indicating a high disease burden at the primary healthcare level. At Puskesmas Imogiri 1, most T2DM patients receive metformin therapy, yet the coverage of care and effectiveness of treatment in achieving optimal glycemic control, particularly HbA1c levels, remain challenging in daily practice. This study aimed to assess the effectiveness of metformin dosage in achieving HbA1c <7% in T2DM patients at Puskesmas Imogiri 1. A quantitative study with a cross-sectional design and total sampling technique was conducted among T2DM patients treated at this facility. The variables studied included type and dosage of metformin therapy and HbA1c levels as indicators of glycemic control, with data collected from medical record reviews, including medication history and the most recent HbA1c test results. Of the 54 respondents, 35.2% achieved HbA1c <7%, while the majority remained above the target. Statistical analysis using Fisher’s Exact Test revealed no significant association between metformin dosage and glycemic control status. Likewise, duration of therapy, sex, and age were not significantly associated with HbA1c achievement (p>0.05). In conclusion, this study indicates that there is no significant relationship between metformin dosage, duration of therapy, age, or sex and the achievement of HbA1c targets in T2DM patients at Puskesmas Imogiri 1.
Mekanisme dan Aktivitas Antidiabetes Clitoria ternatea dalam Pengendalian Glukosa pada Diabetes Melitus Tipe 2 Ester Heny Irenia Siagian; Lisa Kurnia Sari; Felicia Beta Papilaya; Yacobus Christian Prasetyo
Jurnal Kesehatan Masyarakat Indonesia (JKMI) Vol. 4 No. 1 (2026): Oktober
Publisher : Publikasi Inspirasi Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.62017/jkmi.v4i1.9057

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease with a high disease burden that requires long-term management. One herbal ingredient with potential for development as a complementary therapy is the butterfly pea flower (Clitoria ternatea), which contains polyphenols, flavonoids, and anthocyanins with biological activities related to the regulation of glucose metabolism. This study aims to analyze the therapeutic potential and pharmacological mechanisms of C. ternatea extract as an antidiabetic agent in T2DM. The study employed a narrative review design with a mixed-evidence synthesis. A literature search was conducted via Google Scholar and PubMed for publications from 2016 to 2026. Primary articles, including in vitro, in vivo, and human studies, were selected based on inclusion and exclusion criteria, with the selection process adhering to the PRISMA 2020 guidelines. Of the 16,504 articles identified, 11 primary studies met the criteria and were included in the synthesis, comprising 2 human studies, 5 in vivo studies, and 4 in vitro studies. The results indicate that C. ternatea extract has the potential to inhibit α-amylase and/or α-glucosidase activity, reduce glucose release or levels, enhance antioxidant capacity, suppress certain inflammatory mediators, and modulate insulin-related parameters. However, the magnitude of these effects varies depending on the type of solvent, dose, formulation, study model, and outcome parameters. Evidence in humans remains limited, is acute in nature, has not yet involved patients with type 2 diabetes mellitus (T2DM), and does not yet provide data on HbA1c or long-term safety. Thus, C. ternatea has the potential to be developed as a herbal-based complementary therapy for T2DM, but the available evidence is not yet sufficient to support its use as a substitute for standard therapy.